发明人冯建国,韩伟,林芳. "Method for the Synthesis of Axitinib Impurity 45" [P]. 中国发明专利, 专利号 CN 109073319 B, 授权公告日 2024-03-01.
发明人张德明,罗永刚,郭海燕. "A Process for Preparing High-Purity Axitinib Impurity 45" [P]. 中国发明专利, 专利号 CN 112617355 B, 授权公告日 2022-08-12.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of 阿昔替尼杂质45 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2024, 1319, (1), 5555-5560.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿昔替尼杂质45 as an Impurity". Chemosphere, 2010, 1081, 3464-3479.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of Axitinib Impurity 45 Using HRMS and NMR". Environ. Sci. Technol., 2011, 991, 7537-7551.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate 阿昔替尼杂质45 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2018, 1394, (12), 3243-3256.